Korean J Anesthesiol.  2018 Dec;71(6):476-482. 10.4097/kja.d.17.00011.

Effects of adenosine receptor agonist on the rocuronium-induced neuromuscular block and sugammadex-induced recovery

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea. fred0314@gilhospital.com
  • 2Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Korea.
  • 3Department of Anesthesiology and Pain Medicine, Seoul Paik Hospital, Inje University College of Medicine, Seoul, Korea.
  • 4Department of Anesthesiology and Pain Medicine, Ilsan Hospital, Dongguk University College of Medicine, Goyang, Korea.
  • 5Department of Anesthesiology and Pain Medicine, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea.

Abstract

BACKGROUND
Several types of receptors are found at neuromuscular presynaptic membranes. Presynaptic inhibitory A1 and facilitatory A2A receptors mediate different modulatory functions on acetylcholine release. This study investigated whether adenosine A1 receptor agonist contributes to the first twitch tension (T1) of train-of-four (TOF) stimulation depression and TOF fade during rocuronium-induced neuromuscular blockade, and sugammadex-induced recovery.
METHODS
Phrenic nerve-diaphragm tissues were obtained from 30 adult Sprague-Dawley rats. Each tissue specimen was randomly allocated to either control group or 2-chloroadenosine (CADO, 10 μM) group. One hour of reaction time was allowed before initiating main experimental data collection. Loading and boost doses of rocuronium were sequentially administered until > 95% depression of the T1 was achieved. After confirming that there was no T1 twitch tension response, 15 min of resting time was allowed, after which sugammadex was administered. Recovery profiles (T1, TOF ratio [TOFR], and recovery index) were collected for 1 h and compared between groups.
RESULTS
There were statistically significant differences on amount of rocuronium (actually used during experiment), TOFR changes during concentration-response of rocuronium (P = 0.04), and recovery profiles (P < 0.01) of CADO group comparing with the control group. However, at the initial phase of this experiment, dose-response of rocuronium in each group demonstrated no statistically significant differences (P = 0.12).
CONCLUSIONS
The adenosine A1 receptor agonist (CADO) influenced the TOFR and the recovery profile. After activating adenosine receptor, sugammadex-induced recovery from rocuronium-induced neuromuscular block was delayed.

Keyword

Adenosine A₁-receptor; Neuromuscular junction; Neuromuscular nondepolarizing agents; Rocuronium; Sugammadex

MeSH Terms

2-Chloroadenosine
Acetylcholine
Adenosine*
Adult
Data Collection
Depression
Humans
Membranes
Neuromuscular Blockade*
Neuromuscular Junction
Neuromuscular Nondepolarizing Agents
Rats, Sprague-Dawley
Reaction Time
Receptor, Adenosine A1
Receptors, Purinergic P1*
2-Chloroadenosine
Acetylcholine
Adenosine
Neuromuscular Nondepolarizing Agents
Receptor, Adenosine A1
Receptors, Purinergic P1

Cited by  1 articles

Effects of hydrocortisone-presensitized sugammadex on recovery from neuromuscular blockade induced by rocuronium: a rodent in vivo study
Hey-Ran Choi, Hong-Seuk Yang, Jae-Moon Choi, Chungon Park, Junyong In, Yong Beom Kim
Anesth Pain Med. 2022;17(2):182-190.    doi: 10.17085/apm.21076.

Full Text Links
  • KJAE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr